TY - JOUR T1 - CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study JO - Revista Clínica Española (English Edition) T2 - AU - Carriel,J. AU - Muñoz-Jaramillo,R. AU - Bolaños-Ladinez,O. AU - Heredia-Villacreses,F. AU - Menéndez-Sanchón,J. AU - Martin-Delgado,J. SN - 22548874 M3 - 10.1016/j.rceng.2020.10.006 DO - 10.1016/j.rceng.2020.10.006 UR - https://revclinesp.es/en-curb-65-as-predictor-30-day-mortality-articulo-S2254887421000667 AB - ObjectiveThis article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19. MethodsThis work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador. ResultsA total of 247 patients were included (mean age 60 ± 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 ≥ 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress. ConclusionsCURB-65  ≥ 2 was associated with higher 30-day mortality on the univariate (Kaplan–Meier estimator) and multivariate (Cox regression) analysis. ER -